Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 6, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 28
- −1 vs. Q2 2023
- Portfolio value
- $391.3M
- −$55.7M (−12.5%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GILDGilead Sciences, Inc. | Stock | 623,123 | $46.7M | 11.9% | +21,756+3.6% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 671,780 | $39.0M | 10.0% | +164,204+32.4% | Added | History |
| BIIBBiogen Inc. | COM | 104,286 | $26.8M | 6.9% | +8,529+8.9% | Added | History |
| MDTMedtronic plc | Stock | 327,903 | $25.7M | 6.6% | −18,605−5.4% | Reduced | History |
| INCYIncyte Corp | COM | 432,545 | $25.0M | 6.4% | +35,013+8.8% | Added | History |
| CAHCardinal Health Inc | Stock | 264,136 | $22.9M | 5.9% | −120,506−31.3% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 71,884 | $18.6M | 4.7% | −21,039−22.6% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 41,147 | $17.9M | 4.6% | +9,796+31.2% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 159,069 | $17.9M | 4.6% | +10,257+6.9% | Added | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 229,589 | $15.6M | 4.0% | +78,261+51.7% | Added | History |
| CNCCentene Corp | Stock | 223,148 | $15.4M | 3.9% | −21,801−8.9% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 212,995 | $14.8M | 3.8% | +17,704+9.1% | Added | History |
| LHLabcorp Holdings Inc. | COM NEW | 64,857 | $13.0M | 3.3% | −8,247−11.3% | Reduced | History |
| GMEDGlobus Medical Inc | Stock | 221,827 | $11.0M | 2.8% | +221,827 | New | History |
| THCTenet Healthcare Corp | COM NEW | 157,975 | $10.4M | 2.7% | −3,482−2.2% | Reduced | History |
| CTLTCatalent, Inc. | COM | 207,129 | $9.43M | 2.4% | +27,041+15.0% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 52,968 | $9.38M | 2.4% | +24,901+88.7% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 96,048 | $8.50M | 2.2% | −66,620−41.0% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 165,616 | $7.51M | 1.9% | +5,215+3.3% | Added | History |
| BAXBaxter International Inc | Stock | 193,243 | $7.29M | 1.9% | −280,391−59.2% | Reduced | History |
| BRKRBruker Corp | COM | 103,355 | $6.44M | 1.6% | −8,887−7.9% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 115,166 | $4.11M | 1.0% | +14,561+14.5% | Added | History |
| QGENQiagen N.V. | SHS NEW | 100,713 | $4.08M | 1.0% | −26,813−21.0% | Reduced | History |
| ACADAcadia Pharmaceuticals Inc | COM | 179,785 | $3.75M | 1.0% | −20,911−10.4% | Reduced | History |
| LNTHLantheus Holdings, Inc. | Stock | 50,962 | $3.54M | 0.9% | +653+1.3% | Added | History |
| KVUEKenvue Inc. | Stock | 144,017 | $2.89M | 0.7% | +144,017 | New | History |
| AMEDAmedisys Inc | COM | 24,585 | $2.30M | 0.6% | −46,422−65.4% | Reduced | History |
| VIRVir Biotechnology, Inc. | COM | 148,538 | $1.39M | 0.4% | −1,868−1.2% | Reduced | History |
Sold out since Q2 2023 (3)
Positions held at the end of Q2 2023 that are gone from this filing.